Aspire Biopharma Holdings, Inc.
ASBPW
Get informed when a big investor buys or sells
+ FollowMarket Cap$71.75M
Close$
Share Statistics
| Market cap | $71.75 Million |
|---|---|
| Enterprise Value | $59.58 Million |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -93.98% |
|---|---|
| Return on Assets | -81.60% |
| Return on Invested Capital | -61.97% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 610.11 |
| Enterprise Value to EBIT | -8.11 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aspire Biopharma Holdings, Inc.
2 employees
CEO: Mr. Kraig T. Higginson Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge resear...